Replimune (REPL) Interest Expenses (2017 - 2026)
Replimune (REPL) reported Interest Expenses of $259000.0 for Q1 2026, down 82.27% on a YoY basis from $1.5 million in Q1 2025, and down 99.38% sequentially from $41.6 million in Q4 2025.
Replimune (REPL) Interest Expenses (2017 - 2026) Analysis & Trends
Replimune (REPL) has 10 years of Interest Expenses data on file, last reported at $259000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 82.27% year-over-year to $259000.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 22.75% YoY), and the FY2026 full-year result was $312.0 million, up 40.79% from the prior year.
- Interest Expenses fell to $259000.0 in Q1 2026, from $41.6 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $51.0 million in Q2 2022 to a low of -$242000.0 in Q1 2022.
- A 5-year average of $32.9 million and a median of $44.4 million in 2024 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses plunged 103.82% in 2024 and surged 3846.15% in 2025, its largest moves.
- Tracing REPL's Interest Expenses over 5 years: stood at $49.7 million in 2022, then decreased by 5.27% to $47.1 million in 2023, then fell by 5.73% to $44.4 million in 2024, then retreated by 6.26% to $41.6 million in 2025, then slumped by 99.38% to $259000.0 in 2026.
- Business Quant data shows REPL's Interest Expenses at $259000.0 in Q1 2026, $41.6 million in Q4 2025, and $42.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 259,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259,000.00 |
| Mar 31, 2026 | 259,000.00 |
| Dec 31, 2025 | 41.61 Mn |
| Dec 31, 2025 | 41.61 Mn |
| Sep 30, 2025 | 42.32 Mn |
| Sep 30, 2025 | 42.32 Mn |
| Jun 30, 2025 | 43.02 Mn |
| Jun 30, 2025 | 43.02 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 44.39 Mn |
| Dec 31, 2024 | 44.39 Mn |
| Sep 30, 2024 | 45.08 Mn |
| Sep 30, 2024 | 45.08 Mn |
| Jun 30, 2024 | 45.75 Mn |
| Jun 30, 2024 | 45.75 Mn |
| Mar 31, 2024 | -39,000.00 |
| Mar 31, 2024 | -39,000.00 |
| Dec 31, 2023 | 47.09 Mn |
| Dec 31, 2023 | 47.09 Mn |